Grifols, S.A. (BME:GRF)
Spain
· Delayed Price · Currency is EUR 10.33
+0.08 (0.78%)
Jun 27, 2025, 5:35 PM CET
Grifols Revenue
Grifols had revenue of 1.79B EUR in the quarter ending March 31, 2025, with 9.85% growth. This brings the company's revenue in the last twelve months to 7.37B, up 10.76% year-over-year. In the year 2024, Grifols had annual revenue of 7.21B with 9.41% growth.
Revenue (ttm)
7.37B
Revenue Growth
+10.76%
P/S Ratio
0.86
Revenue / Employee
309.77K
Employees
23,833
Market Cap
6.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.21B | 620.41M | 9.41% |
| Dec 31, 2023 | 6.59B | 528.01M | 8.71% |
| Jan 1, 2023 | 6.06B | 1.13B | 22.92% |
| Dec 31, 2021 | 4.93B | -406.92M | -7.62% |
| Dec 31, 2020 | 5.34B | 241.35M | 4.73% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Laboratorios Farmaceuticos Rovi | 767.47M |
| Almirall | 1.03B |
| Faes Farma | 524.02M |
| Pharma Mar | 175.75M |
| Clínica Baviera | 279.53M |
| Laboratorio Reig Jofre | 340.41M |
| Oryzon Genomics | 7.36M |
| Prim, S.A. | 233.36M |
Grifols News
- 17 days ago - XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology - GlobeNewsWire
- 4 weeks ago - Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting - Business Wire
- 4 weeks ago - Grifols lawsuit against Gotham City to proceed after New York court ruling - Seeking Alpha
- 4 weeks ago - US court finds enough evidence to proceed with Grifols lawsuit against Gotham City - Reuters
- 5 weeks ago - Grifols: If This Works Out, It Has Massive Upside - Seeking Alpha
- 6 weeks ago - Grifols S.A. reports Q1 results - Seeking Alpha
- 6 weeks ago - Grifols, S.A. (GRFS) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 6 weeks ago - Grifols says on course to meet 2025 outlook as net profit triples - Reuters